Loading clinical trials...
Loading clinical trials...
Randomized Phase III Trial of Topotecan and Cisplatin Versus Etoposide and Carboplatin in the Treatment of Patients With Previously Untreated Small Cell Lung Cancer and Extensive Disease
Conditions
Interventions
topotecan + cisplatin
Etoposide + carboplatin
Locations
1
Denmark
Dept. Oncology, Rigshospitalet
Copenhagen, Denmark
Start Date
January 1, 2006
Primary Completion Date
December 1, 2013
Completion Date
January 1, 2015
Last Updated
January 26, 2016
NCT06066138
NCT06305754
NCT07190248
NCT07485114
NCT05692635
NCT04253964
Lead Sponsor
Danish Oncological Lung Cancer Group
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions